✦ LIBER ✦

Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5′fluoruracil-based adjuvant chemotherapy

✍ Scribed by María Dolores Giráldez; Juan José Lozano; Míriam Cuatrecasas; Virginia Alonso-Espinaco; Joan Maurel; Maribel Mármol; Carlos Hörndler; Javier Ortego; Vicente Alonso; Pilar Escudero; Gina Ramírez; Christoph Petry; Luis LaSalvia; Kerstin Bohmann; Ralph Wirtz; Aurea Mira; Antoni Castells

Book ID: 115556524
Publisher: John Wiley and Sons
Year: 2012
Tongue: French
Weight: 245 KB
Volume: 132
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.27747

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nuclear Maspin expression is associated

Nuclear Maspin expression is associated with response to adjuvant 5-fluorouracil based chemotherapy in patients with stage III colon cancer

✍ Wolfgang Dietmaier; Marcus Bettstetter; Peter J. Wild; Matthias Woenckhaus; Petr 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 528 KB

## Abstract Maspin, a member of the Serpin protease inhibitor family, is overexpressed in poorly differentiated colorectal tumors and more frequently found in tumors with microsatellite instability. Immunohistochemical nuclear Maspin staining is predominantly seen in tumor cells at the invasion fro

The Role of Serum CEA as a Prognostic In

The Role of Serum CEA as a Prognostic Indicator in Stage II and III Breast Cancer Patients Treated With Adjuvant Chemotherapy

✍ Richard L. Theriault; Gabriel N. Hortobagyi; Herbert A. Fritsche; Debbie Frye; R 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

Validation of the 12-Gene Colon Cancer R

Validation of the 12-Gene Colon Cancer Recurrence Score in NSABP C-07 As a Predictor of Recurrence in Patients With Stage II and III Colon Cancer Treated With Fluorouracil and Leucovorin (FU/LV) and FU/LV Plus Oxaliplatin

✍ Yothers, G.; O'Connell, M. J.; Lee, M.; Lopatin, M.; Clark-Langone, K. M.; Millw 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 334 KB

Assessing the initiation and completion

Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage-III colon cancer

✍ Chung-Yuan Hu; George L. Delclos; Wenyaw Chan; Xianglin L. Du 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 264 KB

Tumor dihydropyrimidine dehydrogenase in

Tumor dihydropyrimidine dehydrogenase in stage II and III colorectal cancer: low level expression is a beneficial marker in oral-adjuvant chemotherapy, but is also a predictor for poor prognosis in patients treated with curative surgery alone

✍ Takashi Tsuji; Terumitsu Sawai; Hiroaki Takeshita; Tohru Nakagoe; Shigekazu Hida 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Adjuvant chemotherapy with oxaliplatin,

Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer: Abstracted from: André T, Boni C, Mounedji-Boudiaf L, et al. Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343–51

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 213 KB